NeoGenomics, Inc. (NEO) Q3 2022 Earnings Call Transcript

Nov. 08, 2022 1:06 PM ETNeoGenomics, Inc. (NEO)
SA Transcripts profile picture
SA Transcripts
133.98K Followers

NeoGenomics, Inc. (NASDAQ:NEO) Q3 2022 Results Conference Call November 8, 2022 8:30 AM ET

Company Participants

Chris Smith - Chief Executive Officer

Bill Bonello - Chief Financial Officer

Vishal Sikri - President of our Pharma Services Division, Inivata

Shashi Kulkarni - President of Lab Operations and CSO

Conference Call Participants

Alex Nowak - Craig-Hallam Capital

Andrew Brackmann - William Blair

David Delahunt - Goldman Sachs

Puneet Souda - SVB Securities

Andrew Cooper - Raymond James

Mark Massaro - BTIG

Mason Carrico - Stephens

Tejas Savant - Morgan Stanley

Dan Brennan - Cowen

Mike Matson - Needham & Company

Operator

Good day, ladies and gentlemen, and welcome to the NeoGenomics Third Quarter 2022 Earnings Call. At this time, all participants have been placed on a listen-only mode and the floor will be open for questions and comments after the presentation.

It is now my pleasure to turn the floor over to your host, Mr. Chris Smith, CEO of NeoGenomics. Chris, the floor is yours.

Chris Smith

Thanks, Jenny, and good morning, everyone. I’d like to welcome you to NeoGenomics’ third quarter 2022 conference call. Joining me for this call from our Fort Myers headquarters are Bill Bonello, our Chief Financial Officer; Vishal Sikri, President of our Pharma Services Division and Inivata; Dr. Shashi Kulkarni, President of Lab Operations and our Chief Scientific Officer.

Before we begin our prepared remarks, Bill will discuss the forward-looking statements and non-GAAP measures used on this call. Bill?

Bill Bonello

This conference call includes forward-looking statements about our 2022 initiatives, 2022 financial outlook, growth opportunities, and anticipated operating results and performance. Each forward-looking statement is subject to risks and uncertainties that could cause actual results to differ materially from those projected in such statements.

Additional information regarding these risk factors appears under the heading Forward-Looking Statements

Recommended For You

Comments

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.